• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.

作者信息

Fürstenau Moritz, Fink Anna Maria, Schilhabel Anke, Weiss Jonathan, Robrecht Sandra, Eckert Robert, de la Serna Javier, Crespo Marta, Coscia Marta, Vitale Candida, Böttcher Sebastian, Weppner Gesche, Ritgen Matthias, Stilgenbauer Stephan, Tausch Eugen, Fischer Kirsten, Hallek Michael, Eichhorst Barbara, Brüggemann Monika, Herling Carmen D

机构信息

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.

Department II of Internal Medicine, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.

出版信息

Blood. 2021 Apr 22;137(16):2267-2271. doi: 10.1182/blood.2020008609.

DOI:10.1182/blood.2020008609
PMID:33512465
Abstract
摘要

相似文献

1
B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide.来那度胺治疗慢性淋巴细胞白血病患者时发生的B细胞急性淋巴细胞白血病
Blood. 2021 Apr 22;137(16):2267-2271. doi: 10.1182/blood.2020008609.
2
Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.硼替佐米联合地塞米松治疗多发性骨髓瘤患者的临床疗效及不良反应观察
Br J Clin Pharmacol. 2019 May;85(5):924-934. doi: 10.1111/bcp.13873. Epub 2019 Feb 27.
3
Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.一名多发性骨髓瘤患者在来那度胺维持治疗期间发生急性淋巴细胞白血病。
Leuk Lymphoma. 2013 Dec;54(12):2753-5. doi: 10.3109/10428194.2013.786072.
4
Simultaneous occurrence of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia.慢性淋巴细胞白血病与急性淋巴细胞白血病同时发生。
Haematologica. 2002 Apr;87(4):EIM11.
5
B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.老年男性患浆细胞骨髓瘤伴长期沙利度胺和来那度胺暴露后的 B 细胞急性淋巴细胞白血病：病例报告及文献复习。
BMC Cancer. 2019 Nov 27;19(1):1147. doi: 10.1186/s12885-019-6286-9.
6
Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia.来那度胺停药后慢性淋巴细胞白血病患者的持续长期反应。
Leukemia. 2018 Oct;32(10):2278-2281. doi: 10.1038/s41375-018-0059-3. Epub 2018 Feb 20.
7
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL.来那度胺和利妥昔单抗治疗初治和复发 CLL 患者的疗效和反应预测因素。
Blood Adv. 2019 May 14;3(9):1533-1539. doi: 10.1182/bloodadvances.2019031336.
8
Venous thromboembolism in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with lenalidomide: a systematic review.来那度胺治疗非霍奇金淋巴瘤或慢性淋巴细胞白血病患者的静脉血栓栓塞症：系统评价。
Leuk Lymphoma. 2018 Nov;59(11):2602-2611. doi: 10.1080/10428194.2018.1448085. Epub 2018 Mar 21.
9
Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.序贯使用奥法妥木单抗和来那度胺治疗复发难治性慢性淋巴细胞白血病和小淋巴细胞淋巴瘤。
Leuk Lymphoma. 2015 Mar;56(3):645-9. doi: 10.3109/10428194.2014.935369.
10
Lenalidomide in the treatment of chronic lymphocytic leukemia.来那度胺治疗慢性淋巴细胞白血病
Expert Opin Investig Drugs. 2017 May;26(5):633-650. doi: 10.1080/13543784.2017.1313230. Epub 2017 Apr 17.

引用本文的文献

1
Characteristics and outcomes of secondary acute lymphoblastic leukemia (sALL) after multiple myeloma (MM): SEER data analysis in a single-center institution.多发性骨髓瘤（MM）后继发性急性淋巴细胞白血病（sALL）的特征与预后：单中心机构的监测、流行病学与最终结果（SEER）数据分析
Cancer Pathog Ther. 2024 Jul 2;3(1):76-80. doi: 10.1016/j.cpt.2024.06.007. eCollection 2025 Jan.
2
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.慢性淋巴细胞白血病：2025年流行病学、发病机制、诊断与治疗最新进展
Am J Hematol. 2025 Mar;100(3):450-480. doi: 10.1002/ajh.27546. Epub 2025 Jan 28.
3
Protein degradation: expanding the toolbox to restrain cancer drug resistance.
蛋白质降解：扩展工具箱以抑制癌症耐药性。
J Hematol Oncol. 2023 Jan 24;16(1):6. doi: 10.1186/s13045-023-01398-5.
4
Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia.除骨髓增生异常综合征和急性髓系白血病之外的治疗相关血液系统肿瘤的风险
Blood. 2023 Feb 23;141(8):951-955. doi: 10.1182/blood.2022018051.
5
Treatment-Associated Acute Lymphoblastic Leukemia Following Autologous Hematopoietic Stem Cell Transplant and Lenalidomide Maintenance in Patients With Multiple Myeloma.自体造血干细胞移植和来那度胺维持治疗多发性骨髓瘤后治疗相关性急性淋巴细胞白血病。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221133204. doi: 10.1177/23247096221133204.
6
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.多发性骨髓瘤治疗后与治疗相关的急性淋巴细胞白血病的独特特征和结局
Blood Cancer J. 2022 Jun 1;12(6):87. doi: 10.1038/s41408-022-00680-y.
7
Altered DNA Methylation Profiles in Mutated CLL Patients.突变 CLL 患者中改变的 DNA 甲基化谱。
Int J Mol Sci. 2021 Aug 28;22(17):9337. doi: 10.3390/ijms22179337.
8
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?免疫能力能否在慢性淋巴细胞白血病中恢复？
Hematol Oncol Clin North Am. 2021 Aug;35(4):827-845. doi: 10.1016/j.hoc.2021.03.010. Epub 2021 May 26.